Answers are grounded in this paper and cite their sources.
Head and neck cancer (HNC) accounted for 4% of all malignancies in 2022 and is often associated with tobacco and alcohol use, but the incidence of human papillomavirus (HPV)–associated HNC has steadily increased in recent decades. Unlike HPV-negative HNC, HPV-positive HNC has a favorable prognosis and survival is significantly better resulting in a large population of HNC survivors. Survivorship for HNC is of the utmost importance as there is a high burden of side effects that impact function and quality of life, and the patients with HPV HNC are living longer with the sequelae of their treatment.
No takes yet. Share an insight, caveat, or question.
Fazer-Posorske et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: